Alternative therapies for neonatal autoimmune thrombocytopenia.
This study was performed to test whether corticosteroids were superior to intravenous immunoglobulins (IVIG) in the treatment of neonatal autoimmune thrombocytopenia (NAT). All cases received IVIG, and unresponsive cases received corticosteroids. Of 7 babies who received IVIG, only 1 responded. The 6 remaining cases received corticosteroids thereafter, and all of them responded well to this therapy. Corticosteroids may be more effective than IVIG in NAT.